Abstract Purpose of Review Lipid measurements and genetic testing are the main diagnostic
tools for FH screening that are available in many countries. A lipid profile is widely …

Highlights•FH is a common inherited autosomal codominant disorder.•Homozygous FH
patients usually have a poor response to traditional lipid-lowering therapy.•We reviewed the …

Background Data mining of electronic health records to identify patients suspected of familial
hypercholesterolemia (FH) has been limited by absence of both phenotypic and genomic …

Familial hypercholesterolemia (FH) is a common genetic disorder of lipid metabolism
caused by pathogenic/likely pathogenic variants in LDLR, APOB, and PCSK9 genes …

Familial hypercholesterolemia (FH) is the most common inherited life-threatening disorder of
lipid metabolism. Early diagnosis and treatment are the key to reduce the cumulative life …

Familial hypercholesterolaemia (FH) is caused by mutations in lipid metabolism genes,
predominantly in low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB) …

Background Familial hypercholesterolemia (FH) is an inherited disorder mainly marked by
increased low-density lipoprotein cholesterol (LDL-C) concentrations and a heightened risk …

Familial hypercholesterolemia (FH) is an autosomal-dominant disorder caused mainly by
substitutions in the low-density lipoprotein receptor (LDLR) gene, leading to an increased …

Clinical impact of genetic testing for lipid disorders : Current Opinion in Cardiology Clinical
impact of genetic testing for lipid disorders : Current Opinion in Cardiology Log in or …

Ailesel Hiperkolesterolemi (AH), kolesterol yüksekliği ile seyreden ve erken yaş
aterosklerotik kardiyovasküler hastalıkların (ASKVH) önlenebilir nedeni olan genetik bir …